Investigators compared the prevalence of HIV among patients hospitalized with COVID-19 compared to the general population and sought to determine whether patients with HIV had higher susceptibility to COVID-19.
Hospitalized patients with COVID-19 more often have a vitamin D deficiency than population-based controls.
Study authors assessed the association between elevated and increasing red blood cell distribution width and increased mortality risk in patients with COVID-19.
For US veterans with unhealthy alcohol use, reducing drinking may improve or resolve various conditions including pain interference symptoms and substance use, although most correlations are not significant.
The FDA approved Veklury (remdesivir; Gilead Sciences) for the treatment of COVID-19 in patients aged ≥12 years (weighing ≥40kg) requiring hospitalization.
The majority of older adults who take multiple medications have never had a comprehensive medication review.
Combined moderate- and high-intensity training has no effect on all-cause mortality compared with recommended physical activity levels.
The NIH-led trial will assess 3 drugs: infliximab, a tumor necrosis factor blocker, abatacept, a selective T cell costimulation modulator, and cenicriviroc, an investigational immunomodulator that blocks 2 chemokine receptors, CCR2 and CCR5.
Restrictions on intravenous opioid products at an academic medical institution during a critical drug shortage were not found to have significant impact on overall institutional opioid utilization.
The US emergency sick leave provision in the Families First Coronavirus Response Act was a highly effective policy tool to flatten the curve in the short run.